Literature DB >> 25093974

Evaluation of QuantiFERON-TB gold in-tube and tuberculin skin tests among immigrant children being screened for latent tuberculosis infection.

Meredith M Howley1, John A Painter, Dolores J Katz, Edward A Graviss, Randall Reves, Suzanne F Beavers, Denise O Garrett.   

Abstract

BACKGROUND: Centers for Disease Control and Prevention requirements for pre-immigration tuberculosis (TB) screening of children 2- to 14-years old permit a tuberculin skin test (TST) or an interferon-gamma release assay (IGRA). Few data are available on the performance of IGRAs versus TSTs in foreign-born children.
METHODS: We compared the performance of TST and QuantiFERON-TB (QFT) Gold In-Tube in children 2- to 14-years old applying to immigrate to the United States from Mexico, the Philippines and Vietnam, using diagnosis of TB in immigrating family members as a measure of potential exposure.
RESULTS: We enrolled 2520 children: 664 (26%) were TST+ and 142 (5.6%) were QFT+. One hundred and eleven (4.4%) were TST+/QFT+, 553 (21.9%) were TST+/QFT- and 31 (1.2%) were TST-/QFT+. Agreement between tests was poor (κ = 0.20). Although positive results of both tests were significantly associated with older age (relative risks [RR] TST+, 1.64; 95% confidence interval [CI]: 1.36-1.97; RR QFT+, 3.05; 95% CI: 1.72-5.38) and with the presence of TB in at least 1 immigrating family member (RR TST+, 1.40; 95% CI: 1.12-1.75; RR QFT+ 2.24; 95% CI: 1.18-4.28), QFT+ results were more strongly associated with both predictive variables.
CONCLUSIONS: The findings support the preferential use of QFT over TST for pre-immigration screening of foreign-born children 2 years of age and older and lend support to the preferential use of IGRAs in testing foreign-born children for latent TB infection.

Entities:  

Mesh:

Year:  2015        PMID: 25093974      PMCID: PMC5136477          DOI: 10.1097/INF.0000000000000494

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  29 in total

1.  The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis.

Authors:  Shingai Machingaidze; Charles Shey Wiysonge; Yulieth Gonzalez-Angulo; Mark Hatherill; Sizulu Moyo; Willem Hanekom; Hassan Mahomed
Journal:  Pediatr Infect Dis J       Date:  2011-08       Impact factor: 2.129

2.  Evaluation of the impact of interferon-gamma release assays on the management of childhood tuberculosis.

Authors:  Daphne I Ling; Claire A Crépeau; Marieke Dufresne; Shazia Khan; Caroline Quach; Nandini Dendukuri; Kevin Schwartzman; Dick Menzies; Larry C Lands; Madhukar Pai
Journal:  Pediatr Infect Dis J       Date:  2012-12       Impact factor: 2.129

3.  Risk factors associated with latent tuberculosis infection in Mexican American children.

Authors:  Janine Young; Mary E O'Connor
Journal:  Pediatrics       Date:  2005-06       Impact factor: 7.124

4.  Tuberculosis in children: New diagnostic blood tests.

Authors:  F Kakkar; Ud Allen; D Ling; M Pai; Ic Kitai
Journal:  Paediatr Child Health       Date:  2010-10       Impact factor: 2.253

5.  Epidemiology of tuberculosis among US- and foreign-born children and adolescents in the United States, 1994-2007.

Authors:  Heather J Menzies; Carla A Winston; Timothy H Holtz; Kevin P Cain; William R Mac Kenzie
Journal:  Am J Public Health       Date:  2010-07-15       Impact factor: 9.308

6.  Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis.

Authors:  A K Detjen; T Keil; S Roll; B Hauer; H Mauch; U Wahn; K Magdorf
Journal:  Clin Infect Dis       Date:  2007-06-15       Impact factor: 9.079

7.  Interferon-gamma release assay improves the diagnosis of tuberculosis in children.

Authors:  Leila Bianchi; Luisa Galli; Maria Moriondo; Giuseppina Veneruso; Laura Becciolini; Chiara Azzari; Elena Chiappini; Maurizio de Martino
Journal:  Pediatr Infect Dis J       Date:  2009-06       Impact factor: 2.129

Review 8.  The burden of childhood tuberculosis: a public health perspective.

Authors:  B J Marais; C C Obihara; R M Warren; H S Schaaf; R P Gie; P R Donald
Journal:  Int J Tuberc Lung Dis       Date:  2005-12       Impact factor: 2.373

Review 9.  Tuberculosis in children.

Authors:  Ben J Marais
Journal:  Pediatr Pulmonol       Date:  2008-04

10.  The BCG World Atlas: a database of global BCG vaccination policies and practices.

Authors:  Alice Zwerling; Marcel A Behr; Aman Verma; Timothy F Brewer; Dick Menzies; Madhukar Pai
Journal:  PLoS Med       Date:  2011-03-22       Impact factor: 11.069

View more
  14 in total

1.  US Postarrival Evaluation of Immigrant and Refugee Children with Latent Tuberculosis Infection Diagnosed Overseas, 2007-2019.

Authors:  Zanju Wang; Drew L Posey; Richard J Brostrom; Sapna Bamrah Morris; Nina Marano; Christina R Phares
Journal:  J Pediatr       Date:  2022-02-01       Impact factor: 6.314

2.  Health Profiles of Newly Arrived Refugee Children in the United States, 2006-2012.

Authors:  Katherine Yun; Jasmine Matheson; Colleen Payton; Kevin C Scott; Barbara L Stone; Lihai Song; William M Stauffer; Kailey Urban; Janine Young; Blain Mamo
Journal:  Am J Public Health       Date:  2015-11-12       Impact factor: 9.308

3.  Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.

Authors:  Tan N Doan; Damon P Eisen; Morgan T Rose; Andrew Slack; Grace Stearnes; Emma S McBryde
Journal:  PLoS One       Date:  2017-11-28       Impact factor: 3.240

4.  Infectious diseases prevalence, vaccination coverage, and diagnostic challenges in a population of internationally adopted children referred to a Tertiary Care Children's Hospital from 2009 to 2015.

Authors:  Sara Sollai; Francesca Ghetti; Leila Bianchi; Maurizio de Martino; Luisa Galli; Elena Chiappini
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

5.  Tuberculosis in Internationally Displaced Children Resettling in Harris County, Texas, USA, 2010-20151.

Authors:  Gabriella S Lamb; Andrea T Cruz; Elizabeth A Camp; Michelle Javier; Jessica Montour; Tamisha Piper; Umair A Shah; Jeffrey R Starke
Journal:  Emerg Infect Dis       Date:  2020-08       Impact factor: 6.883

6.  Risk Factors for Indeterminate Interferon-Gamma Release Assay for the Diagnosis of Tuberculosis in Children-A Systematic Review and Meta-Analysis.

Authors:  Noëmi R Meier; Thomas Volken; Marc Geiger; Ulrich Heininger; Marc Tebruegge; Nicole Ritz
Journal:  Front Pediatr       Date:  2019-05-29       Impact factor: 3.418

7.  Interferon-Gamma Release Assays and Pediatric Public Health Tuberculosis Screening: The San Francisco Program Experience 2005 to 2008.

Authors:  Jennifer A Grinsdale; Shamim Islam; Olivia Chang Tran; Christine S Ho; L Masae Kawamura; Julie M Higashi
Journal:  J Pediatric Infect Dis Soc       Date:  2014-12-15       Impact factor: 5.235

8.  Interferon-γ Release Assays in Children <15 Years of Age.

Authors:  Amina Ahmed; Pei-Jean I Feng; James T Gaensbauer; Randall R Reves; Renuka Khurana; Katya Salcedo; Rose Punnoose; Dolly J Katz
Journal:  Pediatrics       Date:  2020-01       Impact factor: 9.703

9.  Usefulness of interferon-γ release assay for the diagnosis of latent tuberculosis infection in young children.

Authors:  Ki Wook Yun; Young Kwang Kim; Hae Ryun Kim; Mi Kyung Lee; In Seok Lim
Journal:  Korean J Pediatr       Date:  2016-06-30

10.  Recommendations for the screening of paediatric latent tuberculosis infection in indigenous communities: a systematic review of screening strategies among high-risk groups in low-incidence countries.

Authors:  Lena Faust; Anne McCarthy; Yoko Schreiber
Journal:  BMC Public Health       Date:  2018-08-06       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.